U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
175741175741Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCompletedNo Results AvailableAsthmaDrug: Budesonide/Formoterolhttps://ClinicalTrials.gov/show/NCT00255255
175742175742Effect of Simvastatin on CF Airway InflammationCompletedNo Results AvailableCystic FibrosisDrug: Simvastatin treatment for 28 dayshttps://ClinicalTrials.gov/show/NCT00255242
175743175743Study of Glutamine as Prophylaxis for Irinotecan Induced DiarrheaCompletedNo Results AvailableMetastatic Colorectal CancerDrug: Glutamine|Other: Placebohttps://ClinicalTrials.gov/show/NCT00255229
175744175744Policosanol for the Treatment of HypercholesterolemiaCompletedNo Results AvailableHyperlipidemiaDrug: Policosanol supplement (oral capsule) vs. placebohttps://ClinicalTrials.gov/show/NCT00255216
175745175745Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedHas ResultsGastroesophageal Reflux DiseaseDrug: Dexlansoprazole MR|Drug: Dexlansoprazole MRhttps://ClinicalTrials.gov/show/NCT00255190
175746175746Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected PatientsCompletedHas ResultsHepatitis C Virus InfectionDrug: VGX-410 (Mifepristone)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00255177
175747175747Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedHas ResultsEsophagitis, Reflux|Esophagitis, PepticDrug: Dexlansoprazole MR|Drug: Dexlansoprazole MR|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00255164
175748175748Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive EsophagitisCompletedHas ResultsEsophagitis, Reflux|Esophagitis, PepticDrug: Dexlansoprazole MR|Drug: Dexlansoprazole MR|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00255151
175749175749Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late EffectsWithdrawnNo Results AvailableCancer|Cognitive Late EffectsDrug: Atomoxetinehttps://ClinicalTrials.gov/show/NCT00255138
175750175750Role of Soy Supplementation in Prostate Cancer DevelopmentCompletedHas ResultsProstate NeoplasmDrug: Soy Supplement|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00255125
175751175751TAFF-Psychological Treatment of Separation Anxiety DisorderCompletedNo Results AvailableSeparation Anxiety DisorderBehavioral: family based cognitive behavior therapyhttps://ClinicalTrials.gov/show/NCT00255112
175752175752TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to noCompletedNo Results AvailableHIVDrug: TMC125|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00255099
175753175753The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease PatientsCompletedNo Results AvailableAlzheimer DiseaseDrug: Memantinehttps://ClinicalTrials.gov/show/NCT00255086
175754175754Does Reducing Spasticity Permit an Increase in Strength?CompletedNo Results AvailableSpastic Diplegic Cerebral PalsyDrug: baclofenhttps://ClinicalTrials.gov/show/NCT00255073
175755175755Comprehensive Screening for Women at High Genetic Risk for Developing Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00255060
175756175756Safety and Immune Response of Different Pediatric Combination Vaccines.CompletedHas ResultsDiphtheria|Polio|PertussisBiological: DAPTACEL®. (DTaP), IPOL®., and ActHIB®.|Biological: Pentacel®: DTaP-IPV/Hib combined|Biological: DTaP-IPV and ActHIB®|Biological: Pentacel®: DTaP-IPV/Hib combinedhttps://ClinicalTrials.gov/show/NCT00255047
175757175757Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)TerminatedHas ResultsHepatitis C, ChronicBiological: Peginterferon alfa-2b|Biological: Peginterferon alfa-2b|Drug: Ribavirin|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00255034
175758175758Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedNo Results AvailableDiphtheria|Tetanus|Poliomyelitis|Haemophilus Infections|PertussisBiological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vachttps://ClinicalTrials.gov/show/NCT00255021
175759175759Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)TerminatedHas ResultsHepatitis C, ChronicBiological: peginterferon alfa-2b|Drug: ribavirin|Biological: peginterferon alfa-2b|Drug: ribavirinhttps://ClinicalTrials.gov/show/NCT00255008
175760175760Descriptive, Post-marketing, Surveillance Safety Study of Menactra VaccineCompletedHas ResultsMeningitis|Meningococcal DiseaseBiological: None administered in this studyhttps://ClinicalTrials.gov/show/NCT00254995
175761175761Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)CompletedHas ResultsPsoriasisBiological: Infliximabhttps://ClinicalTrials.gov/show/NCT00254982
175762175762Immunogenicity and Safety of Pentaxim in South African InfantsCompletedNo Results AvailableDiphtheria|Tetanus|Haemophilus Infections|Pertussis|PoliomyelitisBiological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hibhttps://ClinicalTrials.gov/show/NCT00254969
175763175763Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent AsthmaCompletedNo Results AvailableRespiratory Tract Diseases|Respiratory Hypersensitivity|AsthmaDrug: ciclesonide (XRP1526)https://ClinicalTrials.gov/show/NCT00254956
175764175764A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled ChildrenCompletedNo Results AvailableLearning Disorders|Child Behavior DisordersDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00254930
175765175765Assessment of the Immunogenicity and Safety of PENTAXIMâ„¢ in PhilippinesCompletedNo Results AvailableDiphtheria|Tetanus|Polio|Pertussis|Haemophilus Influenzae Type BBiological: Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine|Biological: Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccinehttps://ClinicalTrials.gov/show/NCT00254917
175766175766Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLCTerminatedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: Cisplatin|Drug: Gemcitabine|Drug: PF-3512676|Drug: Cisplatin|Drug: Gemcitabine + Cisplatinhttps://ClinicalTrials.gov/show/NCT00254904
175767175767Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung CancerTerminatedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: PF-3512676 + Paclitaxel + Carboplatin|Drug: Paclitaxel + Carboplatinhttps://ClinicalTrials.gov/show/NCT00254891
175768175768Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14CompletedNo Results AvailableADHDDrug: Methylphenidate hydrochloridehttps://ClinicalTrials.gov/show/NCT00254878
175769175769A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female VolunteersCompletedNo Results AvailableContraception|Female ContraceptionDrug: EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.75 mg of ethinyl estradiol (versus CILEST® tablets).https://ClinicalTrials.gov/show/NCT00254865
175770175770Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With AutograftTerminatedNo Results AvailableStenosis|Spondylolisthesis|Degenerative Disc DiseaseProcedure: Posterior Lateral Fusion (PLF)|Procedure: Anterior Lumbar Interbody Fusion (ALIF)|Procedure: Transforaminal lumbar interbody fusion (TLIF)|Procedure: Posterior lumbar interbody fusion (PLIF)|Procedure: Extreme lateral interbody fusion (XLIF)https://ClinicalTrials.gov/show/NCT00254852

* Görseller ve İçerik tekif hakkına sahip olabilir